Preventive role of exogenous testosterone on cisplatin-induced gonadal toxicity: an experimental placebo-controlled prospective trial

Fertility and Sterility

Volumn 93, Issue 5, 2010, Pages 1388-1393

  Aminsharifi, Alireza ^a   Shakeri, Saeed ^a   Ariafar, Ali ^a   Moeinjahromi, Behnam ^a   Kumar, Prikala V ^a   Karbalaeedoost, Saeed ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cisplatin; mouse; spermatogenesis; T; testis

Indexed keywords

CISPLATIN; PLACEBO; TESTOSTERONE ENANTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CISPLATIN INDUCED GONADAL TOXICITY; CISPLATIN INDUCED GONDAL TOXICITY; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG MEGADOSE; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPERMATOGENESIS; SPERMATOZOON COUNT;

ANIMALS; ANTINEOPLASTIC AGENTS; ATROPHY; CISPLATIN; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED BALB C; PLACEBO EFFECT; PROTECTIVE AGENTS; SPERM COUNT; SPERMATOGENESIS; TESTIS; TESTOSTERONE; TIME FACTORS;

EID: 77949273945     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.028     Document Type: Article

References (21)

1. Thomson A.B., Critchley H.O., Kelnar C.J., and Wallace W.H. Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. Best Pract Res Clin Endocrinol Metab 16 (2002) 311-314
2. Magelssen H., Brydoy M., and Fossa S.D. The effects of cancer and cancer treatments on male reproductive function. Nat Clin Pract Urol 3 (2006) 312-322
3. Ishikawa T., Kamidono S., and Fujisawa M. Fertility after high-dose chemotherapy for testicular cancer. Urology 63 (2004) 137-140
4. Pectasides D., Pectasides M., Farmakis D., Nikolaou M., Koumpou M., Kostopoulou V., et al. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy. Eur Urol 45 (2004) 187-193
5. Pont J., and Albrecht W. Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril 68 (1997) 1-5
6. Meistrich M.L. Hormonal stimulation of the recovery of spermatogenesis following chemo- or radiotherapy. Review article. APMIS 106 (1998) 37-45
7. Howell S.J., and Shalet S.M. Testicular function following chemotherapy. Hum Reprod Update 7 (2001) 363-369
8. Liu P.Y., and Handelsman D.J. The present and future state of hormonal treatment for male infertility. Hum Reprod Update 9 (2003) 9-23
9. Seed J., Chapin R.E., Clegg E.D., Dostal L.A., Foote R.H., Hurtt M.E., et al. Methods for assessing sperm motility, morphology, and counts in the rat, rabbit, and dog: a consensus report. ILSI Risk Science Institute Expert Working Group on Sperm Evaluation. Reprod Toxicol 10 (1996) 237-244
10. Meistrich M.L., Finch M., da Cunha M.F., Hacker U., and Au W.W. Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res 42 (1982) 122-131
11. Meistrich M.L. Stage-specific sensitivity of spermatogonia to different chemotherapeutic drugs. Biomed Pharmacother 38 (1984) 137-142
12. Kartalou M., and Essigmann J.M. Recognition of cisplatin adducts by cellular proteins. Mutat Res 478 (2001) 1-21
13. Amory J.K., Page S.T., and Bremner W.J. Drug insight: recent advances in male hormonal contraception. Nat Clin Pract Endocrinol Metab 2 (2006) 32-41
14. Glode L.M., Robinson J., and Gould S.F. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet 1 (1981) 1132-1134
15. Udagawa K., Ogawa T., Watanabe T., Yumura Y., Takeda M., and Hosaka M. GnRH analog, leuprorelin acetate, promotes regeneration of rat spermatogenesis after severe chemical damage. Int J Urol 8 (2001) 615-622
16. Delic J.I., Bush C., and Peckham M.J. Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen. Cancer Res 46 (1986) 1909-1914
17. Meistrich M.L., Wilson G., Kangasniemi M., and Huhtaniemi I. Mechanism of protection of rat spermatogenesis by hormonal pretreatment: stimulation of spermatogonal differentiation after irradiation. J Androl 21 (2000) 464-469
18. Udagawa K., Ogawa T., Watanabe T., Tamura Y., Kita K., and Kubota Y. Testosterone administration promotes regeneration of chemically impaired spermatogenesis in rats. Int J Urol 13 (2006) 1103-1108
19. Meistrich M.L., Wilson G., Porter K.L., Huhtaniemi I., Shetty G., and Shuttlesworth G.A. Restoration of spermatogenesis in dibromochloropropane (DBCP)-treated rats by hormone suppression. Toxicol Sci 76 (2003) 418-426
20. Aminsharifi A.R., Talaei T., Kumar V., Sabayan B., Samani S., and Mohamadhoseini E. A postulated role of testosterone for prevention of cisplatin gonadal toxicity. Med Hypotheses 68 (2007) 525-527
21. Nonomura M., Okada K., Hida S., and Yoshida O. Does a gonadotropin-releasing hormone analogue prevent cisplatin-induced spermatogenic impairment? An experimental study in the mouse. Urol Res 19 (1991) 135-140